Nobilis Health Corp.
NRTSF · OTC
6/30/2018 | 3/31/2018 | 12/31/2017 | 9/30/2017 | |
|---|---|---|---|---|
| Market Cap | $93,823 | $129,003 | $105,292 | $116,708 |
| - Cash | $16,531 | $23,239 | $22,536 | $34,139 |
| + Debt | $139,631 | $140,352 | $136,801 | $88,630 |
| Enterprise Value | $216,923 | $246,116 | $219,557 | $171,199 |
| Revenue | $69,189 | $64,457 | $86,801 | $64,652 |
| % Growth | 7.3% | -25.7% | 34.3% | – |
| Gross Profit | $42,501 | $38,315 | $56,298 | $38,531 |
| % Margin | 61.4% | 59.4% | 64.9% | 59.6% |
| EBITDA | $9,338 | $3,765 | $20,641 | $4,092 |
| % Margin | 13.5% | 5.8% | 23.8% | 6.3% |
| Net Income | $885 | -$3,852 | $3,596 | $1,014 |
| % Margin | 1.3% | -6% | 4.1% | 1.6% |
| EPS Diluted | 0.01 | -0.049 | 0.05 | 0.01 |
| % Growth | 120.3% | -198.6% | 400% | – |
| Operating Cash Flow | $63 | $2,665 | -$1,493 | $9,583 |
| Capital Expenditures | -$697 | -$641 | -$682 | -$1,262 |
| Free Cash Flow | -$634 | $2,024 | -$2,175 | $8,321 |